HEADER HYDROLASE 07-FEB-14 4CPM TITLE STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60/2008 VIRUS IN TITLE 2 COMPLEX WITH OSELTAMIVIR CAVEAT 4CPM NAG D 1 HAS WRONG CHIRALITY AT ATOM C1 NAG B 611 HAS WRONG CAVEAT 2 4CPM CHIRALITY AT ATOM C1 LONG BOND BETWEEN NAG A 605 AND MAN A CAVEAT 3 4CPM 605 G39 A AND B 700 ARE SP3 AT C2 AND C7, EXPECTED SP2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURAMINIDASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.2.1.18 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA B VIRUS (B/BRISBANE/60/2008); SOURCE 3 ORGANISM_TAXID: 604436 KEYWDS HYDROLASE, VIRAL PROTEIN, OSELTAMIVIR EXPDTA X-RAY DIFFRACTION AUTHOR S.G.VACHIERI,P.J.COLLINS,V.ESCURET,J.S.CASALEGNO,N.CATTLE,O.FERRARIS, AUTHOR 2 M.SABATIER,E.FROBERT,V.CARO,J.J.SKEHEL,S.J.GAMBLIN,F.VALLA, AUTHOR 3 M.VALETTE,M.OTTMANN,J.W.MCCAULEY,R.S.DANIELS,B.LINA REVDAT 5 09-OCT-24 4CPM 1 REMARK REVDAT 4 20-DEC-23 4CPM 1 HETSYN REVDAT 3 29-JUL-20 4CPM 1 CAVEAT COMPND REMARK HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 08-OCT-14 4CPM 1 JRNL REVDAT 1 14-MAY-14 4CPM 0 JRNL AUTH V.ESCURET,P.J.COLLINS,J.CASALEGNO,S.G.VACHIERI,N.CATTLE, JRNL AUTH 2 O.FERRARIS,M.SABATIER,E.FROBERT,V.CARO,J.J.SKEHEL,S.GAMBLIN, JRNL AUTH 3 F.VALLA,M.VALETTE,M.OTTMANN,J.W.MCCAULEY,R.S.DANIELS,B.LINA JRNL TITL A NOVEL I221 L SUBSTITUTION IN NEURAMINIDASE CONFERS HIGH JRNL TITL 2 LEVEL RESISTANCE TO OSELTAMIVIR IN INFLUENZA B VIRUSES. JRNL REF J.INFECT.DIS. V. 210 1260 2014 JRNL REFN ISSN 0022-1899 JRNL PMID 24795482 JRNL DOI 10.1093/INFDIS/JIU244 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 32009 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1614 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.2100 - 6.2908 0.83 2422 107 0.1560 0.1906 REMARK 3 2 6.2908 - 4.9952 0.88 2437 122 0.1333 0.1768 REMARK 3 3 4.9952 - 4.3644 0.90 2484 133 0.1100 0.1477 REMARK 3 4 4.3644 - 3.9656 0.92 2523 136 0.1245 0.1639 REMARK 3 5 3.9656 - 3.6815 0.92 2498 149 0.1498 0.2370 REMARK 3 6 3.6815 - 3.4645 0.92 2512 136 0.1653 0.2137 REMARK 3 7 3.4645 - 3.2911 0.94 2574 138 0.1701 0.2394 REMARK 3 8 3.2911 - 3.1479 0.94 2553 141 0.1937 0.3138 REMARK 3 9 3.1479 - 3.0267 0.95 2590 142 0.2230 0.2622 REMARK 3 10 3.0267 - 2.9223 0.97 2612 154 0.2173 0.3126 REMARK 3 11 2.9223 - 2.8309 0.94 2575 108 0.2306 0.3187 REMARK 3 12 2.8309 - 2.7500 0.97 2615 148 0.2594 0.3688 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.440 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 6414 REMARK 3 ANGLE : 1.249 8643 REMARK 3 CHIRALITY : 0.082 934 REMARK 3 PLANARITY : 0.005 1093 REMARK 3 DIHEDRAL : 19.873 2372 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 76:700) REMARK 3 ORIGIN FOR THE GROUP (A): 56.6997 -62.2864 8.6963 REMARK 3 T TENSOR REMARK 3 T11: 0.3352 T22: 0.3667 REMARK 3 T33: 0.3971 T12: -0.0086 REMARK 3 T13: 0.0081 T23: 0.0549 REMARK 3 L TENSOR REMARK 3 L11: 1.3275 L22: 0.8430 REMARK 3 L33: 0.9519 L12: 0.1741 REMARK 3 L13: 0.1513 L23: -0.0373 REMARK 3 S TENSOR REMARK 3 S11: -0.0565 S12: 0.1684 S13: 0.2596 REMARK 3 S21: -0.1118 S22: 0.0322 S23: -0.0859 REMARK 3 S31: -0.0280 S32: 0.0787 S33: 0.0299 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN B AND RESID 76:700) REMARK 3 ORIGIN FOR THE GROUP (A): 22.7099 -82.2931 12.1203 REMARK 3 T TENSOR REMARK 3 T11: 0.3648 T22: 0.3634 REMARK 3 T33: 0.4403 T12: -0.0208 REMARK 3 T13: -0.0735 T23: 0.0081 REMARK 3 L TENSOR REMARK 3 L11: 1.1471 L22: 0.7293 REMARK 3 L33: 0.7431 L12: 0.0219 REMARK 3 L13: -0.0563 L23: -0.1749 REMARK 3 S TENSOR REMARK 3 S11: 0.0263 S12: 0.1064 S13: -0.0182 REMARK 3 S21: -0.0946 S22: -0.0018 S23: 0.1980 REMARK 3 S31: 0.0646 S32: -0.0500 S33: -0.0238 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: (CHAIN A AND RESID 1469:1470) OR (CHAIN B AND RESID REMARK 3 1466:1468) REMARK 3 ORIGIN FOR THE GROUP (A): 45.4113 -71.8851 17.3282 REMARK 3 T TENSOR REMARK 3 T11: 0.7691 T22: 0.3214 REMARK 3 T33: 0.8047 T12: 0.0893 REMARK 3 T13: 0.0961 T23: 0.0347 REMARK 3 L TENSOR REMARK 3 L11: 0.6085 L22: 0.1312 REMARK 3 L33: 0.3174 L12: 0.0116 REMARK 3 L13: -0.0663 L23: 0.0052 REMARK 3 S TENSOR REMARK 3 S11: -0.2349 S12: -0.0407 S13: -0.0264 REMARK 3 S21: -0.0835 S22: 0.2289 S23: -0.1618 REMARK 3 S31: -0.1983 S32: 0.1220 S33: -0.0135 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: (CHAIN A AND RESID 2001:2051) OR (CHAIN B AND RESID REMARK 3 2001:2041) REMARK 3 ORIGIN FOR THE GROUP (A): 40.7723 -73.2975 11.4333 REMARK 3 T TENSOR REMARK 3 T11: 0.2447 T22: 0.3466 REMARK 3 T33: 0.1911 T12: -0.0016 REMARK 3 T13: 0.0068 T23: -0.0031 REMARK 3 L TENSOR REMARK 3 L11: 0.6330 L22: 0.1820 REMARK 3 L33: -0.0220 L12: 0.2238 REMARK 3 L13: 0.1067 L23: -0.0546 REMARK 3 S TENSOR REMARK 3 S11: -0.1590 S12: 0.2433 S13: 0.0568 REMARK 3 S21: -0.2141 S22: 0.1204 S23: 0.0188 REMARK 3 S31: 0.0529 S32: -0.0198 S33: 0.0487 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4CPM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-FEB-14. REMARK 100 THE DEPOSITION ID IS D_1290059695. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32059 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 45.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.64000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4CPL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 1500, 0.1M SUCCINIC ACID PH REMARK 280 9.0. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.23067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.11533 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 30.11533 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 60.23067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 26490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 60.23067 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2007 LIES ON A SPECIAL POSITION. REMARK 375 HOH A2008 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 LEU A 1 REMARK 465 PRO A 2 REMARK 465 SER A 3 REMARK 465 THR A 4 REMARK 465 ILE A 5 REMARK 465 GLN A 6 REMARK 465 THR A 7 REMARK 465 LEU A 8 REMARK 465 THR A 9 REMARK 465 LEU A 10 REMARK 465 PHE A 11 REMARK 465 LEU A 12 REMARK 465 THR A 13 REMARK 465 SER A 14 REMARK 465 GLY A 15 REMARK 465 GLY A 16 REMARK 465 VAL A 17 REMARK 465 LEU A 18 REMARK 465 LEU A 19 REMARK 465 SER A 20 REMARK 465 LEU A 21 REMARK 465 TYR A 22 REMARK 465 VAL A 23 REMARK 465 SER A 24 REMARK 465 ALA A 25 REMARK 465 SER A 26 REMARK 465 LEU A 27 REMARK 465 SER A 28 REMARK 465 TYR A 29 REMARK 465 LEU A 30 REMARK 465 LEU A 31 REMARK 465 TYR A 32 REMARK 465 SER A 33 REMARK 465 ASP A 34 REMARK 465 ILE A 35 REMARK 465 LEU A 36 REMARK 465 LEU A 37 REMARK 465 LYS A 38 REMARK 465 PHE A 39 REMARK 465 SER A 40 REMARK 465 PRO A 41 REMARK 465 THR A 42 REMARK 465 GLU A 43 REMARK 465 ILE A 44 REMARK 465 THR A 45 REMARK 465 ALA A 46 REMARK 465 PRO A 47 REMARK 465 THR A 48 REMARK 465 MET A 49 REMARK 465 PRO A 50 REMARK 465 LEU A 51 REMARK 465 ASP A 52 REMARK 465 CYS A 53 REMARK 465 ALA A 54 REMARK 465 ASN A 55 REMARK 465 ALA A 56 REMARK 465 SER A 57 REMARK 465 ASN A 58 REMARK 465 VAL A 59 REMARK 465 GLN A 60 REMARK 465 ALA A 61 REMARK 465 VAL A 62 REMARK 465 ASN A 63 REMARK 465 ARG A 64 REMARK 465 SER A 65 REMARK 465 ALA A 66 REMARK 465 THR A 67 REMARK 465 LYS A 68 REMARK 465 GLY A 69 REMARK 465 VAL A 70 REMARK 465 THR A 71 REMARK 465 LEU A 72 REMARK 465 LEU A 73 REMARK 465 LEU A 74 REMARK 465 PRO A 75 REMARK 465 MET B 0 REMARK 465 LEU B 1 REMARK 465 PRO B 2 REMARK 465 SER B 3 REMARK 465 THR B 4 REMARK 465 ILE B 5 REMARK 465 GLN B 6 REMARK 465 THR B 7 REMARK 465 LEU B 8 REMARK 465 THR B 9 REMARK 465 LEU B 10 REMARK 465 PHE B 11 REMARK 465 LEU B 12 REMARK 465 THR B 13 REMARK 465 SER B 14 REMARK 465 GLY B 15 REMARK 465 GLY B 16 REMARK 465 VAL B 17 REMARK 465 LEU B 18 REMARK 465 LEU B 19 REMARK 465 SER B 20 REMARK 465 LEU B 21 REMARK 465 TYR B 22 REMARK 465 VAL B 23 REMARK 465 SER B 24 REMARK 465 ALA B 25 REMARK 465 SER B 26 REMARK 465 LEU B 27 REMARK 465 SER B 28 REMARK 465 TYR B 29 REMARK 465 LEU B 30 REMARK 465 LEU B 31 REMARK 465 TYR B 32 REMARK 465 SER B 33 REMARK 465 ASP B 34 REMARK 465 ILE B 35 REMARK 465 LEU B 36 REMARK 465 LEU B 37 REMARK 465 LYS B 38 REMARK 465 PHE B 39 REMARK 465 SER B 40 REMARK 465 PRO B 41 REMARK 465 THR B 42 REMARK 465 GLU B 43 REMARK 465 ILE B 44 REMARK 465 THR B 45 REMARK 465 ALA B 46 REMARK 465 PRO B 47 REMARK 465 THR B 48 REMARK 465 MET B 49 REMARK 465 PRO B 50 REMARK 465 LEU B 51 REMARK 465 ASP B 52 REMARK 465 CYS B 53 REMARK 465 ALA B 54 REMARK 465 ASN B 55 REMARK 465 ALA B 56 REMARK 465 SER B 57 REMARK 465 ASN B 58 REMARK 465 VAL B 59 REMARK 465 GLN B 60 REMARK 465 ALA B 61 REMARK 465 VAL B 62 REMARK 465 ASN B 63 REMARK 465 ARG B 64 REMARK 465 SER B 65 REMARK 465 ALA B 66 REMARK 465 THR B 67 REMARK 465 LYS B 68 REMARK 465 GLY B 69 REMARK 465 VAL B 70 REMARK 465 THR B 71 REMARK 465 LEU B 72 REMARK 465 LEU B 73 REMARK 465 LEU B 74 REMARK 465 PRO B 75 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB CYS A 121 SG CYS A 126 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASP B 193 O2 EDO A 1469 6555 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 201 CA - CB - CG ANGL. DEV. = 14.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 94 -60.92 -99.17 REMARK 500 ASN A 198 61.00 -160.41 REMARK 500 ILE A 220 71.86 51.41 REMARK 500 THR A 223 -157.24 -128.27 REMARK 500 CYS A 290 -159.62 -121.09 REMARK 500 PRO A 335 175.47 -56.70 REMARK 500 SER A 358 44.37 -142.54 REMARK 500 ASP A 383 -165.20 63.02 REMARK 500 TRP A 407 -130.97 -103.82 REMARK 500 LEU A 454 -81.57 -89.40 REMARK 500 ASN B 143 108.35 -53.08 REMARK 500 ALA B 175 132.83 -172.03 REMARK 500 ASP B 193 -158.29 -137.92 REMARK 500 ASN B 198 57.19 -156.53 REMARK 500 ASN B 218 15.58 57.11 REMARK 500 ILE B 220 83.43 59.38 REMARK 500 ASP B 383 -170.22 67.48 REMARK 500 TRP B 407 -124.62 -105.21 REMARK 500 ASP B 416 -165.85 -77.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG A 605 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 500 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 292 O REMARK 620 2 THR A 296 O 75.4 REMARK 620 3 ASP A 323 OD2 71.6 90.5 REMARK 620 4 GLY A 343 O 92.3 87.3 163.8 REMARK 620 5 GLY A 345 O 72.2 144.4 93.0 79.7 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 500 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 292 O REMARK 620 2 THR B 296 O 85.6 REMARK 620 3 ASP B 323 OD2 83.7 95.8 REMARK 620 4 GLY B 343 O 100.3 82.8 175.7 REMARK 620 5 GLY B 345 O 91.9 170.2 93.3 88.3 REMARK 620 6 HOH B2033 O 170.8 103.5 94.0 82.3 79.3 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CPL RELATED DB: PDB REMARK 900 STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60 /2008 VIRUS. REMARK 900 RELATED ID: 4CPN RELATED DB: PDB REMARK 900 STRUCTURE OF THE NEURAMINIDASE FROM THE B/BRISBANE/60 /2008 VIRUS REMARK 900 IN COMPLEX WITH ZANAMIVIR REMARK 900 RELATED ID: 4CPO RELATED DB: PDB REMARK 900 STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/ 15.216/2011 REMARK 900 VIRUS REMARK 900 RELATED ID: 4CPY RELATED DB: PDB REMARK 900 STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/ 15.216/2011 REMARK 900 VIRUS IN COMPLEX WITH OSELTAMIVIR REMARK 900 RELATED ID: 4CPZ RELATED DB: PDB REMARK 900 STRUCTURE OF THE NEURAMINIDASE FROM THE B/LYON/CHU/ 15.216/2011 REMARK 900 VIRUS IN COMPLEX WITH ZANAMIVIR DBREF 4CPM A 0 465 UNP C0LT34 C0LT34_9INFB 1 466 DBREF 4CPM B 0 465 UNP C0LT34 C0LT34_9INFB 1 466 SEQRES 1 A 466 MET LEU PRO SER THR ILE GLN THR LEU THR LEU PHE LEU SEQRES 2 A 466 THR SER GLY GLY VAL LEU LEU SER LEU TYR VAL SER ALA SEQRES 3 A 466 SER LEU SER TYR LEU LEU TYR SER ASP ILE LEU LEU LYS SEQRES 4 A 466 PHE SER PRO THR GLU ILE THR ALA PRO THR MET PRO LEU SEQRES 5 A 466 ASP CYS ALA ASN ALA SER ASN VAL GLN ALA VAL ASN ARG SEQRES 6 A 466 SER ALA THR LYS GLY VAL THR LEU LEU LEU PRO GLU PRO SEQRES 7 A 466 GLU TRP THR TYR PRO ARG LEU SER CYS PRO GLY SER THR SEQRES 8 A 466 PHE GLN LYS ALA LEU LEU ILE SER PRO HIS ARG PHE GLY SEQRES 9 A 466 GLU THR LYS GLY ASN SER ALA PRO LEU ILE ILE ARG GLU SEQRES 10 A 466 PRO PHE ILE ALA CYS GLY PRO ASN GLU CYS LYS HIS PHE SEQRES 11 A 466 ALA LEU THR HIS TYR ALA ALA GLN PRO GLY GLY TYR TYR SEQRES 12 A 466 ASN GLY THR ARG GLY ASP ARG ASN LYS LEU ARG HIS LEU SEQRES 13 A 466 ILE SER VAL LYS LEU GLY LYS ILE PRO THR VAL GLU ASN SEQRES 14 A 466 SER ILE PHE HIS MET ALA ALA TRP SER GLY SER ALA CYS SEQRES 15 A 466 HIS ASP GLY LYS GLU TRP THR TYR ILE GLY VAL ASP GLY SEQRES 16 A 466 PRO ASP ASN ASN ALA LEU LEU LYS VAL LYS TYR GLY GLU SEQRES 17 A 466 ALA TYR THR ASP THR TYR HIS SER TYR ALA ASN LYS ILE SEQRES 18 A 466 LEU ARG THR GLN GLU SER ALA CYS ASN CYS ILE GLY GLY SEQRES 19 A 466 ASN CYS TYR LEU MET ILE THR ASP GLY SER ALA SER GLY SEQRES 20 A 466 VAL SER GLU CYS ARG PHE LEU LYS ILE ARG GLU GLY ARG SEQRES 21 A 466 ILE ILE LYS GLU ILE PHE PRO THR GLY ARG VAL LYS HIS SEQRES 22 A 466 THR GLU GLU CYS THR CYS GLY PHE ALA SER ASN LYS THR SEQRES 23 A 466 ILE GLU CYS ALA CYS ARG ASP ASN SER TYR THR ALA LYS SEQRES 24 A 466 ARG PRO PHE VAL LYS LEU ASN VAL GLU THR ASP THR ALA SEQRES 25 A 466 GLU ILE ARG LEU MET CYS THR ASP THR TYR LEU ASP THR SEQRES 26 A 466 PRO ARG PRO ASN ASP GLY SER ILE THR GLY PRO CYS GLU SEQRES 27 A 466 SER ASN GLY ASP LYS GLY SER GLY GLY ILE LYS GLY GLY SEQRES 28 A 466 PHE VAL HIS GLN ARG MET GLU SER LYS ILE GLY ARG TRP SEQRES 29 A 466 TYR SER ARG THR MET SER LYS THR GLU ARG MET GLY MET SEQRES 30 A 466 GLY LEU TYR VAL LYS TYR ASP GLY ASP PRO TRP ALA ASP SEQRES 31 A 466 SER ASP ALA LEU ALA PHE SER GLY VAL MET VAL SER MET SEQRES 32 A 466 LYS GLU PRO GLY TRP TYR SER PHE GLY PHE GLU ILE LYS SEQRES 33 A 466 ASP LYS LYS CYS ASP VAL PRO CYS ILE GLY ILE GLU MET SEQRES 34 A 466 VAL HIS ASP GLY GLY LYS GLU THR TRP HIS SER ALA ALA SEQRES 35 A 466 THR ALA ILE TYR CYS LEU MET GLY SER GLY GLN LEU LEU SEQRES 36 A 466 TRP ASP THR VAL THR GLY VAL ASP MET ALA LEU SEQRES 1 B 466 MET LEU PRO SER THR ILE GLN THR LEU THR LEU PHE LEU SEQRES 2 B 466 THR SER GLY GLY VAL LEU LEU SER LEU TYR VAL SER ALA SEQRES 3 B 466 SER LEU SER TYR LEU LEU TYR SER ASP ILE LEU LEU LYS SEQRES 4 B 466 PHE SER PRO THR GLU ILE THR ALA PRO THR MET PRO LEU SEQRES 5 B 466 ASP CYS ALA ASN ALA SER ASN VAL GLN ALA VAL ASN ARG SEQRES 6 B 466 SER ALA THR LYS GLY VAL THR LEU LEU LEU PRO GLU PRO SEQRES 7 B 466 GLU TRP THR TYR PRO ARG LEU SER CYS PRO GLY SER THR SEQRES 8 B 466 PHE GLN LYS ALA LEU LEU ILE SER PRO HIS ARG PHE GLY SEQRES 9 B 466 GLU THR LYS GLY ASN SER ALA PRO LEU ILE ILE ARG GLU SEQRES 10 B 466 PRO PHE ILE ALA CYS GLY PRO ASN GLU CYS LYS HIS PHE SEQRES 11 B 466 ALA LEU THR HIS TYR ALA ALA GLN PRO GLY GLY TYR TYR SEQRES 12 B 466 ASN GLY THR ARG GLY ASP ARG ASN LYS LEU ARG HIS LEU SEQRES 13 B 466 ILE SER VAL LYS LEU GLY LYS ILE PRO THR VAL GLU ASN SEQRES 14 B 466 SER ILE PHE HIS MET ALA ALA TRP SER GLY SER ALA CYS SEQRES 15 B 466 HIS ASP GLY LYS GLU TRP THR TYR ILE GLY VAL ASP GLY SEQRES 16 B 466 PRO ASP ASN ASN ALA LEU LEU LYS VAL LYS TYR GLY GLU SEQRES 17 B 466 ALA TYR THR ASP THR TYR HIS SER TYR ALA ASN LYS ILE SEQRES 18 B 466 LEU ARG THR GLN GLU SER ALA CYS ASN CYS ILE GLY GLY SEQRES 19 B 466 ASN CYS TYR LEU MET ILE THR ASP GLY SER ALA SER GLY SEQRES 20 B 466 VAL SER GLU CYS ARG PHE LEU LYS ILE ARG GLU GLY ARG SEQRES 21 B 466 ILE ILE LYS GLU ILE PHE PRO THR GLY ARG VAL LYS HIS SEQRES 22 B 466 THR GLU GLU CYS THR CYS GLY PHE ALA SER ASN LYS THR SEQRES 23 B 466 ILE GLU CYS ALA CYS ARG ASP ASN SER TYR THR ALA LYS SEQRES 24 B 466 ARG PRO PHE VAL LYS LEU ASN VAL GLU THR ASP THR ALA SEQRES 25 B 466 GLU ILE ARG LEU MET CYS THR ASP THR TYR LEU ASP THR SEQRES 26 B 466 PRO ARG PRO ASN ASP GLY SER ILE THR GLY PRO CYS GLU SEQRES 27 B 466 SER ASN GLY ASP LYS GLY SER GLY GLY ILE LYS GLY GLY SEQRES 28 B 466 PHE VAL HIS GLN ARG MET GLU SER LYS ILE GLY ARG TRP SEQRES 29 B 466 TYR SER ARG THR MET SER LYS THR GLU ARG MET GLY MET SEQRES 30 B 466 GLY LEU TYR VAL LYS TYR ASP GLY ASP PRO TRP ALA ASP SEQRES 31 B 466 SER ASP ALA LEU ALA PHE SER GLY VAL MET VAL SER MET SEQRES 32 B 466 LYS GLU PRO GLY TRP TYR SER PHE GLY PHE GLU ILE LYS SEQRES 33 B 466 ASP LYS LYS CYS ASP VAL PRO CYS ILE GLY ILE GLU MET SEQRES 34 B 466 VAL HIS ASP GLY GLY LYS GLU THR TRP HIS SER ALA ALA SEQRES 35 B 466 THR ALA ILE TYR CYS LEU MET GLY SER GLY GLN LEU LEU SEQRES 36 B 466 TRP ASP THR VAL THR GLY VAL ASP MET ALA LEU MODRES 4CPM ASN A 143 ASN GLYCOSYLATION SITE MODRES 4CPM ASN A 283 ASN GLYCOSYLATION SITE MODRES 4CPM ASN B 143 ASN GLYCOSYLATION SITE MODRES 4CPM ASN B 283 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET CA A 500 1 HET NAG A 605 14 HET NAG A 611 14 HET G39 A 700 20 HET EDO A1466 4 HET EDO A1467 4 HET EDO A1468 4 HET EDO A1469 4 HET EDO A1470 4 HET CA B 500 1 HET NAG B 611 14 HET G39 B 700 20 HET EDO B1466 4 HET EDO B1467 4 HET EDO B1468 4 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM CA CALCIUM ION HETNAM G39 (3R,4R,5S)-4-(ACETYLAMINO)-5-AMINO-3-(PENTAN-3-YLOXY) HETNAM 2 G39 CYCLOHEX-1-ENE-1-CARBOXYLIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN G39 OSELTAMIVIR CARBOXYLATE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 NAG 7(C8 H15 N O6) FORMUL 3 BMA 2(C6 H12 O6) FORMUL 3 MAN 2(C6 H12 O6) FORMUL 5 CA 2(CA 2+) FORMUL 8 G39 2(C14 H24 N2 O4) FORMUL 9 EDO 8(C2 H6 O2) FORMUL 20 HOH *92(H2 O) HELIX 1 1 SER A 98 GLY A 103 5 6 HELIX 2 2 SER B 98 GLY B 103 5 6 HELIX 3 3 PRO B 195 ASN B 198 5 4 SHEET 1 AA 4 PHE A 91 ILE A 97 0 SHEET 2 AA 4 HIS A 438 LEU A 447 -1 O THR A 442 N ILE A 97 SHEET 3 AA 4 ASP A 420 ASP A 431 -1 O PRO A 422 N LEU A 447 SHEET 4 AA 4 SER A 409 LYS A 415 -1 O PHE A 410 N GLY A 425 SHEET 1 AB 4 LEU A 112 CYS A 121 0 SHEET 2 AB 4 CYS A 126 ALA A 136 -1 O LYS A 127 N ALA A 120 SHEET 3 AB 4 HIS A 154 LYS A 159 -1 O HIS A 154 N THR A 132 SHEET 4 AB 4 ILE A 170 ALA A 174 -1 O ILE A 170 N SER A 157 SHEET 1 AC 4 GLY A 178 HIS A 182 0 SHEET 2 AC 4 TRP A 187 ASP A 193 -1 O THR A 188 N CYS A 181 SHEET 3 AC 4 LEU A 200 TYR A 205 -1 O LEU A 200 N ASP A 193 SHEET 4 AC 4 ALA A 208 HIS A 214 -1 O ALA A 208 N TYR A 205 SHEET 1 AD 2 ARG A 222 THR A 223 0 SHEET 2 AD 2 ASN A 234 THR A 240 -1 O THR A 240 N ARG A 222 SHEET 1 AE 2 ASN A 229 ILE A 231 0 SHEET 2 AE 2 ASN A 234 THR A 240 -1 O ASN A 234 N ILE A 231 SHEET 1 AF 4 ARG A 259 ILE A 264 0 SHEET 2 AF 4 CYS A 250 ARG A 256 -1 O PHE A 252 N ILE A 264 SHEET 3 AF 4 ASN A 234 THR A 240 -1 O CYS A 235 N ILE A 255 SHEET 4 AF 4 ASN A 229 ILE A 231 -1 O ASN A 229 N TYR A 236 SHEET 1 AG 4 ARG A 259 ILE A 264 0 SHEET 2 AG 4 CYS A 250 ARG A 256 -1 O PHE A 252 N ILE A 264 SHEET 3 AG 4 ASN A 234 THR A 240 -1 O CYS A 235 N ILE A 255 SHEET 4 AG 4 ARG A 222 THR A 223 -1 O ARG A 222 N THR A 240 SHEET 1 AH 5 THR A 267 GLY A 268 0 SHEET 2 AH 5 THR A 310 LEU A 315 1 O ALA A 311 N THR A 267 SHEET 3 AH 5 PRO A 300 ASN A 305 -1 O PHE A 301 N ARG A 314 SHEET 4 AH 5 THR A 285 ALA A 289 -1 O ILE A 286 N LEU A 304 SHEET 5 AH 5 THR A 277 PHE A 280 -1 O THR A 277 N ALA A 289 SHEET 1 AI 4 PHE A 351 ARG A 355 0 SHEET 2 AI 4 ILE A 360 ARG A 366 -1 O GLY A 361 N GLN A 354 SHEET 3 AI 4 MET A 374 TYR A 382 -1 O GLY A 377 N ARG A 366 SHEET 4 AI 4 ALA A 394 PRO A 405 -1 O ALA A 394 N VAL A 380 SHEET 1 BA 4 PHE B 91 ILE B 97 0 SHEET 2 BA 4 HIS B 438 LEU B 447 -1 O THR B 442 N ILE B 97 SHEET 3 BA 4 ASP B 420 ASP B 431 -1 O PRO B 422 N LEU B 447 SHEET 4 BA 4 SER B 409 LYS B 415 -1 O PHE B 410 N GLY B 425 SHEET 1 BB 4 LEU B 112 CYS B 121 0 SHEET 2 BB 4 CYS B 126 ALA B 136 -1 O LYS B 127 N ALA B 120 SHEET 3 BB 4 HIS B 154 LYS B 159 -1 O HIS B 154 N THR B 132 SHEET 4 BB 4 ILE B 170 ALA B 174 -1 O ILE B 170 N SER B 157 SHEET 1 BC 5 ALA B 208 HIS B 214 0 SHEET 2 BC 5 LEU B 200 TYR B 205 -1 O LEU B 201 N TYR B 213 SHEET 3 BC 5 TRP B 187 ASP B 193 -1 O TYR B 189 N LYS B 204 SHEET 4 BC 5 SER B 177 HIS B 182 -1 O SER B 177 N VAL B 192 SHEET 5 BC 5 SER B 226 ALA B 227 1 O SER B 226 N ALA B 180 SHEET 1 BD 2 ARG B 222 THR B 223 0 SHEET 2 BD 2 ASN B 234 THR B 240 -1 O THR B 240 N ARG B 222 SHEET 1 BE 2 ASN B 229 ILE B 231 0 SHEET 2 BE 2 ASN B 234 THR B 240 -1 O ASN B 234 N ILE B 231 SHEET 1 BF 4 ARG B 259 ILE B 264 0 SHEET 2 BF 4 ARG B 251 ARG B 256 -1 O PHE B 252 N ILE B 264 SHEET 3 BF 4 ASN B 234 THR B 240 -1 O CYS B 235 N ILE B 255 SHEET 4 BF 4 ASN B 229 ILE B 231 -1 O ASN B 229 N TYR B 236 SHEET 1 BG 4 ARG B 259 ILE B 264 0 SHEET 2 BG 4 ARG B 251 ARG B 256 -1 O PHE B 252 N ILE B 264 SHEET 3 BG 4 ASN B 234 THR B 240 -1 O CYS B 235 N ILE B 255 SHEET 4 BG 4 ARG B 222 THR B 223 -1 O ARG B 222 N THR B 240 SHEET 1 BH 5 THR B 267 GLY B 268 0 SHEET 2 BH 5 THR B 310 LEU B 315 1 O ALA B 311 N THR B 267 SHEET 3 BH 5 PRO B 300 ASN B 305 -1 O PHE B 301 N ARG B 314 SHEET 4 BH 5 THR B 285 ARG B 291 -1 O ILE B 286 N LEU B 304 SHEET 5 BH 5 GLU B 274 PHE B 280 -1 O GLU B 274 N ARG B 291 SHEET 1 BI 4 PHE B 351 ARG B 355 0 SHEET 2 BI 4 ILE B 360 ARG B 366 -1 O GLY B 361 N GLN B 354 SHEET 3 BI 4 MET B 374 TYR B 382 -1 O GLY B 377 N ARG B 366 SHEET 4 BI 4 ALA B 394 PRO B 405 -1 O ALA B 394 N VAL B 380 SSBOND 1 CYS A 86 CYS A 419 1555 1555 2.04 SSBOND 2 CYS A 121 CYS A 126 1555 1555 2.03 SSBOND 3 CYS A 181 CYS A 228 1555 1555 2.04 SSBOND 4 CYS A 230 CYS A 235 1555 1555 2.03 SSBOND 5 CYS A 276 CYS A 290 1555 1555 2.05 SSBOND 6 CYS A 278 CYS A 288 1555 1555 2.05 SSBOND 7 CYS A 317 CYS A 336 1555 1555 2.05 SSBOND 8 CYS A 423 CYS A 446 1555 1555 2.04 SSBOND 9 CYS B 86 CYS B 419 1555 1555 2.04 SSBOND 10 CYS B 121 CYS B 126 1555 1555 2.04 SSBOND 11 CYS B 181 CYS B 228 1555 1555 2.04 SSBOND 12 CYS B 230 CYS B 235 1555 1555 2.03 SSBOND 13 CYS B 276 CYS B 290 1555 1555 2.04 SSBOND 14 CYS B 278 CYS B 288 1555 1555 2.05 SSBOND 15 CYS B 317 CYS B 336 1555 1555 2.05 SSBOND 16 CYS B 423 CYS B 446 1555 1555 2.04 LINK ND2 ASN A 143 C1 NAG A 611 1555 1555 1.45 LINK ND2 ASN A 283 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN B 143 C1 NAG B 611 1555 1555 1.43 LINK ND2 ASN B 283 C1 NAG D 1 1555 1555 1.43 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.43 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.45 LINK O3 BMA C 3 C1 MAN C 4 1555 1555 1.44 LINK O6 BMA C 3 C1 MAN C 5 1555 1555 1.45 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.45 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.46 LINK O ASP A 292 CA CA A 500 1555 1555 2.77 LINK O THR A 296 CA CA A 500 1555 1555 2.37 LINK OD2 ASP A 323 CA CA A 500 1555 1555 2.86 LINK O GLY A 343 CA CA A 500 1555 1555 2.38 LINK O GLY A 345 CA CA A 500 1555 1555 2.53 LINK O ASP B 292 CA CA B 500 1555 1555 2.36 LINK O THR B 296 CA CA B 500 1555 1555 2.47 LINK OD2 ASP B 323 CA CA B 500 1555 1555 2.76 LINK O GLY B 343 CA CA B 500 1555 1555 2.83 LINK O GLY B 345 CA CA B 500 1555 1555 2.32 LINK CA CA B 500 O HOH B2033 1555 1555 2.70 CISPEP 1 GLN A 137 PRO A 138 0 1.51 CISPEP 2 THR A 324 PRO A 325 0 2.70 CISPEP 3 GLN B 137 PRO B 138 0 2.42 CISPEP 4 THR B 324 PRO B 325 0 -1.14 CRYST1 159.501 159.501 90.346 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006270 0.003620 0.000000 0.00000 SCALE2 0.000000 0.007239 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011069 0.00000